Although amyotrophic lateral sclerosis (ALS) was identified as a neurological condition 150
years ago, risk factors related to the onset and progression of ALS remain largely unknown …

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults and
is characterized by neurodegeneration of motor neurons in the brain and spinal cord. The …

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. It is typically
fatal within 2–5 years of symptom onset. The incidence of ALS is largely uniform across most …

Sporadic amyotrophic lateral sclerosis (ALS) is believed to be a complex disease in which
multiple exogenous and genetic factors interact to cause motor neuron degeneration …

An evidence-based medicine approach was applied to evaluate analytic studies of
exogenous risk factors for amyotrophic lateral sclerosis (ALS) published since 1991 …

Amyotrophic lateral sclerosis is a neurodegenerative disease predominantly affecting upper
and lower motor neurons, resulting in progressive paralysis and death from respiratory …

Background The genetic basis of amyotrophic lateral sclerosis (ALS) is not entirely clear.
While there are families with rare highly penetrant mutations in Cu/Zn superoxide dismutase …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor
neurons, resulting in worsening weakness of voluntary muscles until death occurs from …

Provided with the increasing number of patients diagnosed with ALS and the improved
societal awareness of the disease, more resources should be allocated to the research and …

Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease affecting
motor neurons with an incidence of about 1/100,000. Most ALS cases are sporadic, but 5 …